RxDoctor Payments Data

Loay Kabbani, MD

Vascular Surgery · Detroit, MINPI 1073578407

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Bolton Medical Inc at 29.4% of the total. Reporting peaked in 2022 at $11,463 and has fallen 97.8% since, to $249 in 2025.

$18,957in general payments, 2019–2025

Across 80 payments — averaging $236.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bolton Medical Inc$6K
  • Abbott$5K
  • Cardiva Medical, Inc.$3K
  • Haemonetics Corporation$2K
  • W. L. Gore & Associates, Inc.$2K
  • Endologix LLC$791
  • plus $814 from 9 others
$158,995in research payments, 2019–2025

Across 35 payments — averaging $4542.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$76K
  • Bard Peripheral Vascular, Inc.$41K
  • Abbott$28K
  • Phraxis, Inc.$13K
  • Sonavex, Inc.$2K

What the payments were for

  • Consulting fees$4,37523%
  • Speaking & faculty fees$1,5838%
  • Travel & lodging$7,63540%
  • Food & beverage$3,36418%
  • Education$2,00011%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,957 in reported general payments places this provider in the 85th percentile of 183 vascular surgery providers in Michigan.

See all vascular surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$65,525
Medicare patients
531
Services billed
724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$5,371
Cilostazol13$662
ClopidogrelClopidogrel Bisulfate23$290
Atorvastatin Calcium15$222

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →